MesalazineChronic tubulointerstitial nephritis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1780卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71718-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：227 / 227

相关论文

共 50 条

[41] Ipilimumab/NivolumabAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1985 (1) : 270 - 270
[42] AdalimumabUnmasking of tubulointerstitial nephritis and uveitis: case report
Reactions Weekly, 2021, 1838 (1) : 20 - 20
[43] MesalazineAcute tubulointerstitial nephritis and glomerulosclerosis: case report
Reactions Weekly, 2023, 1957 (1) : 356 - 356
[44] Nivolumab/rabeprazoleAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2018, 1730 (1) : 236 - 236
[45] MesalazineChronic interstitial nephritis and end-stage renal disease: case report
Reactions Weekly, 2015, 1552 (1) : 154 - 154
[46] SitagliptinAcute tubulointerstitial nephritis (ATIN): case report
Reactions Weekly, 2016, 1616 (1) : 142 - 142
[47] MesalazineAcute and chronic tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1966 (1) : 205 - 205
[48] EscitalopramAcute interstitial nephritis leading to tubulointerstitial nephritis and uveitis: case report
Reactions Weekly, 2023, 1960 (1) : 192 - 192
[49] FlurbiprofenFirst report of tubulointerstitial nephritis and uveitis syndrome: case report
Reactions Weekly, 2013, 1438 (1) : 17 - 17
[50] PembrolizumabIgG4-tubulointerstitial nephritis: case report
Reactions Weekly, 2024, 2036 (1) : 388 - 388

← 1 2 3 4 5 →